The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
Open accessAbstract
BACKGROUND: Which medication, if any, to use to prevent the headache of pediatric migraine has not been established. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of amitriptyline (1 mg per kilogram of body weight per day), topiramate (2 mg per kilogram per day), and placebo in children and adolescents 8 to 17 years of age with migraine. Patients were randomly assigned in a 2:2:1 ratio to receive one of the medications or placebo. The primary outcome was a relative reduction of 50% or more in the number of headache days in the comparison of the 28-day baseline period with the last 28 days of a 24-week trial. Secondary outcomes were headache-related disability, headache days, number of trial completers, and serious adverse events that emerged during treatment. RESULTS: A total of 361 patients underwent randomization, and 328 were included in the primary efficacy analysis (132 in the amitriptyline group, 130 in the topiramate group, and 66 in the placebo group). The trial was concluded early for futility after a planned interim analysis. There were no significant between-group differences in the primary outcome, which occurred in 52% of the patients in the amitriptyline group, 55% of those in the topiramate group, and 61% of those in the placebo group (amitriptyline vs. placebo, P=0.26; topiramate vs. placebo, P=0.48; amitriptyline vs. topiramate, P=0.49). There were also no significant between-group differences in headache-related disability, headache days, or the percentage of patients who completed the 24-week treatment period. Patients who received amitriptyline or topiramate had higher rates of several adverse events than those receiving placebo, including fatigue (30% vs. 14%) and dry mouth (25% vs. 12%) in the amitriptyline group and paresthesia (31% vs. 8%) and weight loss (8% vs. 0%) in the topiramate group. Three patients in the amitriptyline group had serious adverse events of altered mood, and one patient in the topiramate group had a suicide attempt. CONCLUSIONS: There were no significant differences in reduction in headache frequency or headache-related disability in childhood and adolescent migraine with amitriptyline, topiramate, or placebo over a period of 24 weeks. The active drugs were associated with higher rates of adverse events. (Funded by the National Institutes of Health; CHAMP ClinicalTrials.gov number, NCT01581281 ).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
The International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,049
Olesen, J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00824.x · Cited by 2,056
TEST REVIEW behavior rating inventory of executive function.
Gioia, G. A., Isquith, P. K., Guy, S. C., & Kenworthy, L. (2000) · Child Neuropsychology · doi:10.1076/chin.6.3.235.3152 · Cited by 1,925
Rating scales to assess depression in school-aged children.
Kovács, M. (1981) · PubMed · Cited by 1,924
Stewart, W. F. (1992) · JAMA · doi:10.1001/jama.267.1.64 · Cited by 1,583
Lost productive time and cost due to common pain conditions in the US workforce
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.290.18.2443 · Cited by 1,570
Behavior Rating Inventory for Executive Function
Gioia, G. A., Isquith, P. K., & Roth, R. M. (2017) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-56782-2_1881-2 · Cited by 1,568
Prevalence of headache and migraine in schoolchildren
Abu-Arefeh, I., & Russell, G. (1994) · BMJ · doi:10.1136/bmj.309.6957.765 · Cited by 764
Price, D. D., Milling, L. S., Kirsch, I., Duff, A., Montgomery, G. H., & Nicholls, S. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00081-0 · Cited by 561
Cited by
Ashina, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1915327 · Cited by 816
Migraine: integrated approaches to clinical management and emerging treatments
Ashina, M., Buse, D. C., Ashina, H., Pozo-Rosich, P., Peres, M. F. P., Lee, M. J., Terwindt, G. M., Halker Singh, R., Tassorelli, C., Do, T. P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32342-4 · Cited by 305
Applying a biopsychosocial model to migraine: rationale and clinical implications
Rosignoli, C., Ornello, R., Onofri, A., Caponnetto, V., Grazzi, L., Raggi, A., Leonardi, M., & Sacco, S. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01471-3 · Cited by 138
Behavioral Interventions for Migraine
Pérez-Muñoz, A., Buse, D. C., & Andrasik, F. (2019) · Neurologic Clinics · doi:10.1016/j.ncl.2019.07.003 · Cited by 58
Grazzi, L., Grignani, E., Raggi, A., Rizzoli, P., & Guastafierro, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182211739 · Cited by 19
Metadata
- Authors
- Powers, S. W., Coffey, C. S., Chamberlin, L. A., Ecklund, D. J., Klingner, E. A., Yankey, J. W., Korbee, L. L., Porter, L. L., & Hershey, A. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-01-12
- Volume
- 376
- Issue
- 2
- Pages
- 115-124
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2540692073
- Cited by
- 370
- References
- 25
- FWCI
- 33.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. https://app.cochat.ai/papers/10.1056/nejmoa1610384
- The paper
- Powers, S. W., Coffey, C. S., Chamberlin, L. A., Ecklund, D. J., Klingner, E. A., Yankey, J. W., Korbee, L. L., Porter, L. L., & Hershey, A. D. (2017). Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1610384
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.